Tero Oinonen has been appointed as a new CEO

4Pharma board has appointed Tero Oinonen the company’s new CEO from Jan 1st 2018 onwards.

Tero moves from University of Helsinki where his role was development of business collaboration. Tero has significant experience from Pharmaceutical industry. He has been GM and Vice President of sales & marketing functions in Nordic organizations of Novartis and AstraZeneca.

Tero has also served as board member of 4Pharma since 2016.